To cite this paper use one of the standards below:
Mitochondrial impairment and defective mitophagy are key features of Parkinson’s disease (PD), particularly in models involving mutations in PINK1 and Parkin, where mitochondrial clearance is compromised. These alterations increase oxidative stress and impair energy homeostasis, ultimately contributing to neuronal degeneration. Saccharomyces cerevisiae has proven to be a valuable model for dissecting mitochondrial dynamics and autophagic pathways due to its evolutionary conservation of core mechanisms and genetic accessibility. Epidemiological data consistently link caffeine consumption with reduced PD risk, suggesting that this compound may act as a modulator of neuronal resilience. While the neuroprotective association is well described, the cellular and molecular mechanisms remain unclear. In particular, whether caffeine directly affects mitochondrial quality control processes such as mitophagy has not been fully explored. In this study, wild-type (WTOM) and mitophagy-deficient (ΔATG32) yeast strains were cultured under standard conditions and treated with caffeine at 0 µM, 100 µM, 500 µM, 1000 µM, and 2000 µM. Cultures were normalized to OD600 0.2 before treatment. Preliminary analyses using fluorescence microscopy of mitochondria-targeted reporters revealed that caffeine modulates mitochondrial turnover in a concentration-dependent manner. Notably, WT cells exhibited increased mitochondrial fragmentation and vacuolar colocalization at intermediate concentrations (500–1000 µM), whereas ΔATG32 cells did not show this response, reinforcing the role of Atg32-dependent mitophagy. Higher concentrations (2000 µM) suggested a possible cytotoxic threshold, reflected in altered cell density and reduced signal consistency. Together, these findings suggest that caffeine interacts with mitophagy pathways in yeast, potentially enhancing mitochondrial clearance under stress conditions. By bridging epidemiological observations and mechanistic insights, our results highlight caffeine as a candidate modulator of mitochondrial quality control. These outcomes not only strengthen the role of S. cerevisiae as a simplified platform for studying PD-related processes but also support future investigations into dietary compounds as potential therapeutic adjuvants in neurodegenerative diseases.
This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and the Federal University of Santa Maria.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper